Coexistent Vitiligo and Psoriasis Triggered by Anti-PD-1 Therapy.
0/5 보강
APA
Gao Z, Wu X (2026). Coexistent Vitiligo and Psoriasis Triggered by Anti-PD-1 Therapy.. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 32(2), e66. https://doi.org/10.1097/RHU.0000000000002303
MLA
Gao Z, et al.. "Coexistent Vitiligo and Psoriasis Triggered by Anti-PD-1 Therapy.." Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, vol. 32, no. 2, 2026, pp. e66.
PMID
41277581
같은 제1저자의 인용 많은 논문 (5)
- β-glucan nanotubes improve oral doxorubicin delivery for colorectal cancer by microbiota-mediated colon targeting and reduced toxicity.
- Advancing Point-of-Care Testing for toward CRISPR-Cas-Enabled Diagnostics.
- High-Volume Dilution of Drug-Eluting Beads Reduces Severe Pain After DEB-TACE: A Single-Center Retrospective Study.
- Insulin-like growth factor binding protein-3 serves as a biomarker for resistance to enzalutamide in prostate cancer.
- Neoadjuvant or conversion anti-PD-1/PD-L1 immunotherapy combined with chemotherapy improves 2-year survival and achieves high pathological complete response rate in patients with stage IIB-IIIB small-cell lung cancer.